Doctor's Guide -- MONTREAL -- October 27, 2010 -- Patients treated with rosuvastatin or atorvastatin achieve lipid targets following ST-elevation myocardial infarction (STEMI), according to a study presented here at the 2010 Canadian Cardiovascular Congress (CCC).
